Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response
Immunotherapy using dendritic cells (DCs) is a promising treatment modality for cancer. However, the limited number of functional DCs from peripheral blood has been linked to the unsatisfactory clinical efficacies of current DC-based cancer immunotherapies. We previously generated proliferating anti...
Main Authors: | Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, Yuichiro Hagiya, Hirotake Tsukamoto, Tianyi Liu, Tatsuaki Iwama, Masateru Yamamoto, Chiahsuan Lin, Ryusuke Nakatsuka, Yuta Mishima, Noriko Watanabe, Takashi Yamada, Satoru Senju, Shin Kaneko, Alimjan Idiris, Tetsuya Nakatsura, Hideki Ohdan, Yasushi Uemura |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1814620 |
Similar Items
-
Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy
by: Hiroaki Mashima, et al.
Published: (2021-06-01) -
A novel cardiac differentiation method of a large number and uniformly-sized spheroids using microfabricated culture vessels
by: Tatsuaki Miwa, et al.
Published: (2020-12-01) -
Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention
by: Kavitha Yaddanapudi, et al.
Published: (2019-03-01) -
A Functional GM-CSF Receptor on Dendritic Cells Is Required for Efficient Protective Anti-Tumor Immunity
by: Emily Charrier, et al.
Published: (2021-08-01) -
SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes
by: Markus D. Lacher, et al.
Published: (2018-05-01)